Published January 19, 1987 | Version v1
Patent

Compounds for site-enhanced delivery of radionuclides and uses thereof

Creators

Description

A dihydropyridine ↔ pyridinium salt type of redox, or chemical, delivery system for the site-specific and/or site-enhanced delivery of a radionuclide to the brain is provided. A chelating agent capable of chelating with a radionuclide and having a reactive hydroxyl, carboxyl, amino, amide or imide group is coupled to a carrier moiety comprising a dihydropyridine ↔ pyridinium salt nucleus and then complexed with a radionuclide to provide a new radiopharmaceutical that, in its lipoidal dihydropyridine form, penetrates the blood-brain barrier ('BBB') and allows increased levels of radionuclide concentration in the brain, particularly since oxidation of the dihydropyridine carrier moiety in vivo to the ionic pyridinium salt retards elimination from the brain while elimination from the general circulation is accelerated. This radionuclide delivery system is well suited for use in scintigraphy and similar radiographic techniques

Availability note (English)

Available from the Patents Office, Private Bag X400, Pretoria, 0001, South Africa.

Additional details

Publishing Information

Imprint Pagination
259 p.
IPC:
Int. Cl. C 07 D; A 61 K; A 61 M.
IPC
Int. Cl. C 07 D; A 61 K; A 61 M.
Patent number
ZA patent document 85/5476/A/

Optional Information

Secondary number(s)
US priority 632,314.